Company Directory / research

PrivateFor profitresearchBurlington, United States
Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.
Size
11-50 people: larger than 33% of companies with a size listed
Age
9 years old.
Reach
Website ranked #5,454,990 in the world for traffic, about 1k visits a month.
BiotechnologyHealth CareMedicalPharmaceutical
Funding, as listed
$603M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Cardurion Pharmaceuticals, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Cardurion Pharmaceuticals raised $260 million in a Series B financing round. The company also presented positive clinical results from its CARDINAL-HF Phase 2a clinical trial of a PDE9 inhibitor in patients with heart failure.
Summaries written by the source dataset, not by us, and not checked.
research in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.